Since elevated blood glucose is the most important stimulus for insulin secretion, this mechanism of action leads to the hypothesis that SGLT2i could be beneficial in treating horses with ID, by lowering hyperinsulinemia and subsequently preventing laminitis. The gene discussed is INS; the disease is Hyperinsulinemia.